For more popular FAQs, click here.

Click Ctrl+F (On Windows) or Cmd+F (On Mac) to look for word of interest, or find latest FAQs on top of each section.
Updated 24 Aug 2022

Singapore's COVID-19 Vaccination Programme

 Are Short-Term Pass holders eligible to receive the COVID-19 vaccine under the National Vaccination Programme?
A:  The following groups of short-term pass holders are eligible to be vaccinated against COVID-19 under the National Vaccination Programme, fully subsidised by the Singapore Government:
  • Training Employment Pass
  • Training Work Permit
  • Work Holiday Pass
  • Special Pass
  • Short-Term Visit Pass with a validity period of at least 60 days

You may walk in to any vaccination centre with supporting immigration documents to receive your vaccination.

 How can I check my vaccination record? 
A: For STPHs, you can access your vaccination records on TraceTogether app within a few days after vaccination. You can also access your vaccinated status on both TraceTogether app and Notarise website (using SingPass to logon) after fulfilling the prevailing minimum waiting period when you are fully vaccinated. 

For STVPs, you can access your vaccination records on TraceTogether app. You can also access your vaccinated status on TraceTogether app (using passport number to logon) after fulfilling the prevailing minimum waiting period when you are fully vaccinated.

Alternatively, you may refer to your physical vaccination card, which is given to all individuals vaccinated in Singapore, for your vaccination information.

 Am I eligible to make a claim under the Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination (VIFAP)? 
A:  Short-term pass holders are not covered by the Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination (VIFAP). Any medical bills incurred following the vaccination will be subject to prevailing charging policies.
 Among those who have taken COVID-19 vaccination(s) overseas, who can get their overseas COVID-19 vaccination records ingested into the National Immunisation Registry (NIR)?
A:

Singapore Citizens, Permanent Residents, and Long-Term Pass Holders who have received COVID-19 vaccinations overseas with COVID-19 vaccines authorised by the Heath Sciences Authority under the Pandemic Special Access Route (PSAR) or listed on the World Health Organization’s Emergency Use Listing (WHO EUL) can have their vaccination records updated in the National Immunisation Registry (NIR)  when they return to Singapore. To do so, they should have documentation to show proof of their overseas vaccination and a positive serology test result in Singapore.

To update their vaccination records in Singapore, individuals can visit an approved provider onboard this initiative with their overseas COVID-19 vaccination documentation. Upon a positive serology result, the provider will update the vaccination record in the NIR and will be reflected on individuals’ Trace Together App or HealthHub App.

More details on the process, including the list of the approved providers, can be found here.

 How can I register to receive mRNA vaccines?
A:

For those aged 5 to 11, parents/guardians will have to first register their child/ward at child.vaccine.gov.sg. An SMS with a personalised booking link will be sent to the registered mobile number of the parent/guardian within three to five working days to book a vaccination appointment at selected polyclinics and Public Health Preparedness Clinics (PHPCs) via the National Appointment System.

Please visit gowhere.gov.sg/vaccine to locate the nearest polyclinic or PHPC offering paediatric vaccines.

Under the National Vaccination Programme, children/wards below 18 must have the consent of their parents/guardians to receive their vaccination. They must bring a duly completed and signed hard or electronic copy of the parental consent form, which can be downloaded here.

The following groups of individuals may receive their vaccinations via the following means:

  • Individuals aged 12 to 17 may walk in to any Joint Testing and Vaccination Centre (JTVC) offering the Pfizer-BioNTech/Comirnaty vaccine.
  • Individuals aged 18 and above may walk in to any JTVC.
  • Seniors aged 60 and above may walk in to any JTVC or participating PHPCs.

Individuals mentioned above may also receive their vaccination at polyclinics and PHPCs. Vaccinations at polyclinics will only be accepted on appointment basis, with the exception of seniors aged 80 years and above who may walk in for their vaccination. Individuals who wish to receive their vaccination at participating PHPCs are strongly encouraged to make an appointment with the PHPC to avoid long waiting times.

Holders of Training Employment Pass, Training Work Permit, Work Holiday Pass, Special Pass and Short Term Visit Pass with a pass validity period of at least 60 days may walk in to any JTVC to receive their vaccination. You should bring along identifying documents such as your passport or approval of extension for verification. No prior booking or registration is required.
 How can I register to receive Sinovac-CoronaVac?
 A:

We strongly recommend that you receive the mRNA vaccine or Novavax/Nuvaxovid to complete your primary vaccination series and booster doses, in view of the lower efficacy of the Sinovac-CoronaVac vaccine.

For primary vaccination series:

If you are medically ineligible for the mRNA vaccine and were previously invited to receive the Sinovac-CoronaVac vaccine under a special public health programme, follow the instructions in your SMS invitation to continue with the regime.

For booster:

If you are medically ineligible for the mRNA vaccine and Novavax/Nuvaxovid, you may consider receiving the Sinovac-CoronaVac vaccine as a booster. The Sinovac-CoronaVac vaccine is otherwise not recommended as a booster vaccine.

  How can I register to receive the Novavax/Nuvaxovid COVID-19 vaccine?
A: 

Individuals may walk in to JTVC Bishan to receive their Novavax/Nuvaxovid vaccine.

Eligible individuals who wish to complete their primary series or booster vaccination with Novavax/Nuvaxovid can also book an appointment using the link from their existing SMS invite, to receive their vaccination at JTVC Bishan or any of the selected polyclinics and PHPCs.

 

Which Long-Term Pass Holders are eligible to receive fully-subsidised COVID-19 vaccinations under the National Vaccination Programme?

A:

The following pass holders are eligible to receive fully-subsidised COVID-19 vaccinations under the National Vaccination Programme as Long-Term Pass Holders:

  • Employment Pass
  • S-Pass
  • Work Permit holders (including Confinement Nannies)
  • Student’s Pass
  • Dependant’s Pass
  • MFA-issued IDs
  • Long Term Visit Pass (and LTVP+)

 

Will Singaporeans and Permanent Residents residing overseas be given the vaccines?

A:

Vaccinations will only be administered in Singapore, and Singaporeans and Permanent Residents medically eligible for the vaccinations have to return to Singapore.

 What is the Pandemic Special Access Route (PSAR) and the Special Access Route (SAR)?
 A:Pandemic Special Access Route (PSAR)
The Health Sciences Authority (HSA) has introduced a Pandemic Special Access Route (PSAR) to facilitate Singapore's early access to critical novel vaccines, medicines, and medical devices during a pandemic, such as the current COVID-19 pandemic. Vaccines that are PSAR-authorised are robustly and thoroughly reviewed by HSA’s regulators and international scientific standards.

PSAR authorised vaccines which are recommended for use by the Expert Committee on COVID-19 Vaccination are also made available to the public under the national vaccination programme.

Moderna/Spikevax, Sinovac-CoronaVac and Novavax/Nuvaxovid COVID-19 Vaccines are currently the only PSAR-authorised vaccines in Singapore. The Pfizer-BioNTech/Comirnaty vaccine has been converted from PSAR interim authorisation to full registration since 10 December 2021. These vaccines are also covered under the national vaccination programme.

Special Access Route (SAR) for unauthorised COVID-19 vaccines
The Special Access Route (SAR) applies only to COVID-19 vaccines that are granted Emergency Use List (EUL) by the World Health Organization (WHO), and have not been authorised under the PSAR by HSA. These vaccines:
  • Have not been evaluated for the required quality, safety and efficacy standards for import and supply in Singapore by HSA; and
  • Are not subject to HSA’s enforcement and compliance checks on whether they are adulterated, counterfeit or substandard. 
MOH will continue to monitor the situation and may update the list of PSAR and SAR vaccines in due course.
 

[Updated 24 Aug] How is the vaccination administered?

A:

This vaccine is given as an injection into the muscle of your upper arm.

The primary vaccination series with the mRNA vaccines or Novavax/Nuvaxovid consists of 2 doses, with a recommended interval of 8 weeks between doses.. 

The primary vaccination series with the Sinovac-CoronaVac vaccine consists of 3 doses, with the second dose recommended at 8 weeks after the first dose, and the third dose 3 months (90 days) after the second dose. 

All persons aged 12 years and above are also recommended to receive a booster dose five months after completing primary vaccination series, to achieve longer lasting protection.

Persons in the following groups are also recommended to receive a second booster from about five months after receiving their first booster dose:

• All persons aged 60 years and above;
• Persons living in aged care facilities, such as nursing homes;
• Medically vulnerable persons at higher risk of severe disease
 

How will the government assist persons who suffer from serious side effects following vaccination? Do current insurance policies cover serious side effects related to vaccines?

A:

Like all vaccines, most people who receive the COVID-19 vaccines do not experience side effects. Some may experience mild symptoms, such as pain at the injection site and mild fever, that resolve on their own in a few days. In very rare instances, persons may experience serious side effects, such as a severe allergic reaction.

The Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination (VIFAP) provides one-time goodwill financial assistance to persons who experience serious side effects that are assessed to be related to COVID-19 vaccines administered in Singapore.

To qualify for the VIFAP, individuals must be a Singapore Citizen, Permanent Resident or Long-Term Pass Holder who had received the COVID-19 vaccination in Singapore [1] and experienced a serious side effect that is potentially life-threatening or fatal that required inpatient hospitalisation or caused persistent incapacity or disability. A doctor must assess if the serious side effects are linked to the COVID-19 vaccination received by the individual.

To apply for VIFAP, individuals will need to submit an application accompanied by medical information on the serious side effect from their treating doctor. As the severity of serious side effects can be broad-ranging and the clinical assessment by doctors may vary, all VIFAP applications will be assessed and adjudicated by a MOH-appointed independent clinical panel comprising experts in relevant fields such as neurology, immunology and infectious diseases.

More information on how to apply can be found here.

[1] Using COVID-19 vaccines which are approved under the Health Sciences Authority (HSA)’s Pandemic Special Access Route (PSAR) and/or registered under the Health Products Act.


 

What type of financial assistance will I receive from the Vaccine Injury Financial Assistance Programme (VIFAP)?

A:

The quantum of the one-time goodwill pay-out under the VIFAP is based on the severity of the serious side effects attributed to the COVID-19 vaccines. Persons may qualify for one of the following tiers of pay-out:

i)  One-time pay-out of $2,000 for individuals who required inpatient hospitalisation and medical intervention, and subsequently recovers;
ii)  One-time pay-out of $10,000 for individuals who required admission to High Dependency or Intensive Care, and subsequently recovers; and
iii)  One-time pay-out of $225,000 for individuals who die or suffer permanent severe disability as a result of COVID-19 vaccination.

The VIFAP is not meant to reimburse medical costs. It provides an additional layer of financial support, on top of the existing government healthcare financing schemes for medical costs incurred, which include government subsidies, MediShield Life, MediSave and MediFund.

The VIFAP will be open for applications from 17 March 2021. More information on how to apply can be found here


 I have received the Sinovac-CoronaVac vaccine.  Am I eligible for the VIFAP?
 AYou are eligible for the VIFAP if you receive the Sinovac-CoronaVac vaccine after 23 Oct 2021.

If you had received the Sinovac-CoronaVac vaccine before 23 Oct 2021 but it was offered to you due to an allergic reaction to the first dose of the mRNA vaccine, you would also be eligible for VIFAP.  

What should I take note of on vaccination day?
A: • Bring your ID (NRIC/FIN/Student Pass) for both appointments
• Please turn up on time
• Please wear short sleeved attire, or sleeves loose enough to be rolled up
• If you are unwell, or had fever in the past 24 hours, stay home and postpone your appointments
 

Can I be vaccinated if I am ill on the day of vaccination?

A:

If you are unwell, please reschedule your vaccination at appointments.vaccine.gov.sg or by clicking on the booking link sent via SMS to your phone at registration.


 

I have missed my vaccination appointment. What should I do?

A:

As much as possible, please turn up for your appointment to avoid denying someone else an appointment slot and to ensure a smooth vaccination process. Nevertheless, we understand that there could be extenuating circumstances (e.g. on MC, personal reasons) which could result in the appointment being missed. If you have missed your appointment, please rebook your appointment via the National Appointment System as soon as possible.

 

 Can my COVID-19 vaccine doses be of different brands?
A:Persons Vaccinated with Pfizer-BioNTech/Comirnaty, Moderna/Spikevax Vaccine or Novavax/Nuvaxovid

The primary vaccination series (e.g. first 2 doses) should be completed using the same brand of vaccine i.e. Pfizer-BioNTech/Comirnaty, Moderna/Spikevax, or Novavax/Nuvaxovid. However, any of these vaccines can be used for the booster vaccination, regardless of the vaccine adopted for the primary vaccination series.

The Sinovac-CoronaVac vaccine is not recommended for use as a booster vaccination, except in persons who are medically ineligible to receive the mRNA vaccines and Novavax/Nuvaxovid.

Persons Vaccinated with Sinovac-CoronaVac

Persons who had received two doses of the Sinovac-CoronaVac vaccines but are able to receive the mRNA vaccines are strongly recommended to receive one of the mRNA vaccines as the third dose of the primary vaccination series. Persons are recommended to receive a third dose of the Sinovac-CoronaVac vaccine to complete the primary vaccination series, if they are medically ineligible to receive the mRNA vaccine or Novavax/Nuvaxovid.

Persons who had received two or more doses of the Sinovac-CoronaVac vaccines, and have completed their three-dose primary vaccination series are recommended to receive a booster dose with an mRNA vaccine or Novavax/Nuvaxovid, if they are medically eligible to do so. Persons should only receive the Sinovac-CoronaVac vaccine as a booster if they are medically ineligible to receive the mRNA vaccines and Novavax. 


 Can Short-Term Visitors receive COVID-19 vaccinations and boosters in Singapore
 

Yes, all short-term visitors to Singapore who are aged 18 years and above, may receive paid COVID-19 vaccinations and boosters under the Private Vaccination Programme (PVP). The list of participating clinics can be found at https://www.vaccine.gov.sg/locations/pvp.


Click the back button on your browser or click here for the main page on FAQs.